購(gòu)物車(chē)
幫助
021-54845833/15800441009
中文名稱(chēng)：小鼠抗IFITM2單克隆抗體
|
Background: |
IFN-induced antiviral protein which inhibits the entry of viruses to the host cell cytoplasm, permitting endocytosis, but preventing subsequent viral fusion and release of viral contents into the cytosol. Active against multiple viruses, including influenza A virus, SARS coronavirus (SARS-CoV), Marburg virus (MARV), Ebola virus (EBOV), Dengue virus (DNV), West Nile virus (WNV), human immunodeficiency virus type 1 (HIV-1) and vesicular stomatitis virus (VSV). Can inhibit: influenza virus hemagglutinin protein-mediated viral entry, MARV and EBOV GP1,2-mediated viral entry, SARS-CoV S protein-mediated viral entry and VSV G protein-mediated viral entry. Induces cell cycle arrest and mediates apoptosis by caspase activation and in p53-independent manner. |
|
Applications: |
WB, IHC |
|
Name of antibody: |
IFITM2 |
|
Immunogen: |
Fusion protein of human IFITM2 |
|
Full name: |
interferon induced transmembrane protein 2 |
|
Synonyms: |
1-8D; DSPA2c |
|
SwissProt: |
Q01629 |
|
IHC positive control: |
Human appendix tissue and Human liver tissue |
|
IHC Recommend dilution: |
200-500 |
|
WB Predicted band size: |
15 KD |
|
WB Positive control: |
HepG2, NCI-H460 cell lysates |
|
WB Recommended dilution: |
500-2000 |
